High Ridge Partners

High Ridge Partners is a Chicago-based professional services firm specializing in restructuring, turnaround management, and insolvency services, with a significant focus on the life sciences and healthcare sectors. The firm frequently serves as an Assignee for the Benefit of Creditors (ABC) or as a court-appointed receiver for distressed biotechnology and pharmaceutical companies. High Ridge Partners manages the liquidation of assets, the sale of intellectual property portfolios, and the orderly wind-down of operations for firms that have failed to secure funding or clinical success. Notable engagements include overseeing the asset sales and liquidations for companies such as MabVax Therapeutics and Opexa Therapeutics. By facilitating these transitions, the firm plays a critical role in the financial lifecycle and asset redistribution within the biotech ecosystem.